Redeye: Egetis Q1 2023 - Our comment
Redeye returns with a research update following the Q1 report. We reiterate our base case for now and conclude that 2023, including Q2, will be eventful.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/